Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trametinib access study in BRAF V600E/K-mutant advanced cutaneous melanoma
2014-005149-40Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trametinib in cutaneous melanoma (CM), melanoma, sponsored by GSK. Started Jan 2015; status: completed.
02
Drugs
trametinib
03
Conditions
cutaneous melanoma (CM)melanoma
Beyond the preview
Go deeper on 2014-005149-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005149-40.